CC

Chemours Co

Materials · USD

CC

Price

$21.7

+0.70%

Cap

$3.2B

Earnings

2/4 beat

30d Trend

+1%

CC
Loading chart data...
0 data pointsPowered by Brain47
52-week range95%
9.1322.43

Near 52-week highs — limited upside before resistance

Analyst consensus (12 analysts)-15% to target
0 Strong Buy5 Buy5 Hold2 Sell0 Strong Sell

Target range: $13$23 (consensus: $18.4)

Consensus: Hold

Earnings history

Q4 2025

BEAT

0.05 vs 0.01

Q3 2025

MISS

0.2 vs 0.26

Q2 2025

BEAT

0.58 vs 0.46

Q1 2025

MISS

0.13 vs 0.17

VolatilityLow

Key macro factors

·

Rising Oil Prices: As a specialty chemicals company, Chemours' production costs are likely sensitive to the price of oil, a key raw material. The ongoing Middle East conflict could drive these costs higher, potentially impacting the company's profitability.

·

Global Economic Growth Slowdown: With the IMF set to downgrade global growth forecasts, demand for industrial and specialty chemicals in various end markets (such as coatings, plastics, refrigeration, and transportation) served by Chemours could decrease, affecting sales volumes and pricing.

·

US Economy and Industrial Demand: A strong US economy and robust job market, as indicated by recent job growth and low unemployment, could provide a counterbalance by sustaining domestic industrial demand for some of Chemours' products. However, given Chemours' global presence, worldwide economic trends also play a significant role.

The Chemours Company is a global chemistry company that provides industrial and specialty chemical products to customers in markets such as coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas.

Next earnings:2026-05-05

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Chemours Co (CC) — Brain47 AI Score 55/100 | Analysis